Compounds > cystic fibrosis transmembrane conductance regulator (505-511)
Page last updated: 2024-09-03

cystic fibrosis transmembrane conductance regulator (505-511) and Disease, Pulmonary

cystic fibrosis transmembrane conductance regulator (505-511) has been researched along with Disease, Pulmonary in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ratjen, F1

Reviews

1 review(s) available for cystic fibrosis transmembrane conductance regulator (505-511) and Disease, Pulmonary

ArticleYear
New pulmonary therapies for cystic fibrosis.
    Current opinion in pulmonary medicine, 2007, Volume: 13, Issue:6

    Topics: Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Genetic Therapy; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lung Diseases; Peptide Fragments; Sodium Channel Blockers; Treatment Outcome

2007